Trials / Completed
CompletedNCT00680329
Glaucoma Adherence Study, Spain
A Pilot Study of Adherence Assessment With the Travalert™ Dosing Aid in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma Who Are Treated With the Travoprost/Timolol Maleate Fixed Combination Every Evening
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate adherence to DuoTrav® when reinforced by the use of the Travalert™ Dosing Aid.
Detailed description
This study was conducted in Spain. An identical study was conducted in France, UK, Italy, and Netherlands under Protocol ID EMD-07-01. A combined enrollment number is presented.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost 0.004%/timolol 0.05% fixed combination eye drops (DuoTrav) | One drop in study eye(s) once daily in the evening for four months |
| DEVICE | Travalert Dosing Aid | Approved device used with DuoTrav and intended to provide an objective system for quantifying dosing and improving patient adherence |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-05-20
- Last updated
- 2012-05-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00680329. Inclusion in this directory is not an endorsement.